Novotny HR, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation 1961; 24: 82-86.

2. Wolfe DR. Fluorescein angiography: basic science and engineering. Ophthalmology 1986; 93: 1617-1620.

3. Yannuzzi LA, Rohrer KT, Tindel LJ, et al. Fluorescein angiography complication survey. Ophthalmology 1986; 93: 611-617.

4. Jumper JM, Fu AD, McDonald HR, Johnson RN, Ai E. Fluorescein angiography. In : Alfaro DV, Liggett PE, Mieler WF, Quiroz-Mercado H, Jager RD, Tano Y, eds. Age-related macular degeneration. Lippincott Williams&Wilkins; Philadelphia 2006: 86-100.

5. Spaide RF. Fundus angiography. In: Holz FG, Pauleikhoff D, Spaide RF, Bird AC, eds. Age-related macular degeneration. Springer; Heidelberg 2004: 87-107.

6. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988; 32: 375-413.

7. Pauleikhoff D, Zuels S, Sheraidah GS, et al. Correlation between biochemical composition and fluorescein binding of deposits in Bruch’s membrane. Ophthalmology 1992; 99: 1548-1553.

8. Spaide RF. Fundus autofluorescence and age-related macular degeneration. Ophthalmology 2003; 110: 392-399.

9. Pieramici DJ, Bressler SB. Fluorescein angiography. In: Berger JW, Fine SL, Maguire MG, eds. Age-related macular degeneration. Mosby; St. Louis: 219-236.

10. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967; 63: 567-659.

11. Bressler NM, Bressler SB, Alexander J, et al. Loculated fluid. A previously undescribed fluorescein angiographic finding in choroidal neovascularization associated with macular degeneration. Macular Photocoagulation Study Reading Center. Arch Ophthalmol 1991; 109: 211-215.

12. Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment – TAP and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253-1268.

13. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991; 109: 1242-1257.

14. Gass JDM. Serous retinal pigment detachment with a notch. Retina 1984; 4: 205-220.

15. Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments. A study of 40 eyes. Arch Ophthalmol 1990; 108: 1687-1693.

16. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-434.

17. Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy. Retina 1990 ; 10 : 1-8.

18. Arias L, Caminal J, Rubio M, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol 2007; 17: 992-995.

19. Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 2005; 25: 119-134.

20. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143: 566-83.